GlaxoSmithKline plc (GSK) Earns “Neutral” Rating from JPMorgan Chase & Co.
GSK has been the subject of several other research reports. Shore Capital reiterated a hold rating on shares of GlaxoSmithKline plc in a research note on Wednesday, July 27th. BNP Paribas reiterated a neutral rating and issued a GBX 1,430 ($18.67) price objective on shares of GlaxoSmithKline plc in a research note on Sunday, July 3rd. Goldman Sachs Group Inc. reiterated a buy rating and issued a GBX 1,800 ($23.50) price objective on shares of GlaxoSmithKline plc in a research note on Tuesday, July 12th. Citigroup Inc. reiterated a buy rating on shares of GlaxoSmithKline plc in a research note on Thursday, June 23rd. Finally, Morgan Stanley increased their price objective on shares of GlaxoSmithKline plc from GBX 1,500 ($19.58) to GBX 1,650 ($21.54) and gave the company an equal weight rating in a research note on Monday, July 11th. Three equities research analysts have rated the stock with a sell rating, sixteen have issued a hold rating and eight have assigned a buy rating to the stock. The stock presently has an average rating of Hold and an average target price of GBX 1,676.44 ($21.88).
Shares of GlaxoSmithKline plc (LON:GSK) opened at 1645.00 on Friday. The company has a 50 day moving average price of GBX 1,655.81 and a 200 day moving average price of GBX 1,530.22. GlaxoSmithKline plc has a 52 week low of GBX 1,227.50 and a 52 week high of GBX 1,716.50. The company’s market capitalization is GBX 79.96 billion.
The firm also recently declared a dividend, which will be paid on Thursday, October 13th. Shareholders of record on Thursday, August 11th will be paid a GBX 19 ($0.25) dividend. This represents a yield of 1.12%. The ex-dividend date of this dividend is Thursday, August 11th.
In other GlaxoSmithKline plc news, insider Slaoui,Moncef purchased 28 shares of the stock in a transaction on Friday, August 12th. The stock was acquired at an average cost of GBX 2,208 ($28.82) per share, with a total value of £618.24 ($807.00). Also, insider Witty,Sir Andrew P sold 10,000 shares of the business’s stock in a transaction on Wednesday, July 27th. The stock was sold at an average price of GBX 1,693 ($22.10), for a total transaction of £169,300 ($220,989.43).
GlaxoSmithKline plc Company Profile
GlaxoSmithKline plc (GSK) is a healthcare company. The Company is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. The Company’s segments include Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare.
Receive News & Ratings for GlaxoSmithKline plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline plc and related companies with Analyst Ratings Network's FREE daily email newsletter.